维普中文期刊产品整合服务
16篇 您的检索式:作者名="Aaron G R"
    题名 作者 年代 出处 被引量
1Structural and near-IR photophysical studies on ternary lanthanide complexes containing poly(pyrazolyl)borate and 1,3-diketonate ligands显示文摘DAVIES G M AARONS R J MOTSON G R 2004Dalton Trans2004,8,:1
2The United Kingdom public health re- sponse to an imported laboratory confirmed case of a no- vel coronavirus in September 2012显示文摘Pebody R G Chand M A Thomas H L Green H K Boddington N L Carvalho C Brown C S Anderson S R Rooney C Crawley-Boevey E Irwin D J Aarons E Tong C Newsholme W Price N Langrish C Tucker D Zhao H Phin N Crofts J Bermingham A Gil- gunn-Jones E Brown K E Evans B Catchpole M Watson J M 2012Euro Surveill2012,17,20:1
3Enduring effect of chronic corticosterone treatment on spatial learning,synaptic plasticity,and hippocampal neuropathology in young and mid-aged rats显示文摘SHARI R B AARON G H JEMMIFER C L 1995J Neurosci1995,15,1:1
4Multiplexed toxin analysis using four colors of quantum dot fluororeagents 显示文摘Ellen R G Aaron R C George P A 2004Anlytical Chemistry2004,76,:1
5Potentiation of pa- clitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/ protein kinase B (Akt)-mediated signaling pathway 显示文摘Dao M N Aaron G C Rishindra R 2004The Journal of Thoracic and Cardiovascular Surgery2004,,127:1
6Effectiveness of parks in protecting tropical biodiversity显示文摘Aaron G B Raymond E G Richard E R 2001Science2001,291,5501:1
7Production of α-1,3-galactosyltransferase knockout Pigs by nuclear transfer cloning显示文摘 Donna K S Kwang W P Hee T C Julia L G Gi S I Melissa S Aaron B August R Billy N D Clifton N M David B C Robert J H Randall S P 2002Science2002,295,5557:1
8Second phase dissolution显示文摘AARON H B KOTLER G R 1971Metall Trans1971,2,2:1
9Mammalian cell gene mutation assays working group report 显示文摘Aaron C S Bolcsfodi G Glatt H R 1994Mutat Res1994,312,3:1
10Growth kinetics of precipitates显示文摘AARON H B FAINSTAIN D KOTLER G R 1970J Appl Phys1970,41,12:1
11Management of Pancreatic Pseudocysts显示文摘Hadar Spivak John R Galloway J Richard Amerson Aaron S Fink Gene D Branum Richard D Redvanly William S Richardson Susan J Mauren J Patrick Waring John G Hunter 1998Journal of the American College of Surgeons1998,,5:1
12Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin显示文摘Shirly P Aaron G R Hongyan L 2004Science2004,304,:1
13Diffusion-limited phase transformation: A comparison and critical evaluation of the mathematical approximations 显示文摘AARON H B FAINSTEIN D KOTLER G R 1970Journal of Applied Physics1970,41,11:1
14Solving models of controlled dynamic planar rigid body systems with frictional contact 显示文摘Aaron G Uluc S Alfred A R 2005The International Journal of Robotics Research2005,24,:1
15Artificial intelligence for pancreatic cancer detection: Recent development and future direction显示文摘Artificial intelligence(AI)has been increasingly utilized in medical applications,especially in the field of gastroenterology.AI can assist gastroenterologists in imaging-based testing and prediction of clinical diagnosis,for examples,detecting polyps during colonoscopy,identifying small bowel lesions using capsule endoscopy images,and predicting liver diseases based on clinical parameters.With its high mortality rate,pancreatic cancer can highly benefit from AI since the early detection of small lesion is difficult with conventional imaging techniques and current biomarkers.Endoscopic ultrasound(EUS)is a main diagnostic tool with high sensitivity for pancreatic adenocarcinoma and pancreatic cystic lesion.The standard tumor markers have not been effective for diagnosis.There have been recent research studies in AI application in EUS and novel biomarkers to early detect and differentiate malignant pancreatic lesions.The findings are impressive compared to the available traditional methods.Herein,we aim to explore the utility of AI in EUS and novel serum and cyst fluid biomarkers for pancreatic cancer detection.Passisd Laoveeravat Priya R Abhyankar Aaron R Brenner Moamen M Gabr Fadlallah G Habr Amporn Atsawarungruangkit 2021Artificial Intelligence in Gastroenterology2021,2,2:0
16Pharmacological characterizationof synthetic cannabinoid MAM-2201:radioligand binding and abuse-related effects显示文摘OBJECTIVE Over 30% of all new psychoactive substances identified by the UN Office on Drugs and Crime in 2016 were synthetic cannabinoids.The recent emergence of MAM-2201 on the illicit market is troubling because this drug has no precedent in either the scientific or patent literature,and appears to be a novel compound developed specifically as a 'graymarket' drug of abuse bystructurally combining the known synthetic cannabinoids JWH-122 and AM-2201.There is currently no published information regarding the pharmacology of MAM-2201.METHODS The present studies characterized cannabinoid-like effects of MAM-2201 in vitro(interactions with cannabinoid type 1 receptors[CB1 Rs]) and in vivo(in mice and rats).RESULTS In a radioligand binding assay using [3 H]CP55,940 in HEK cell membranes transfected with the CB1 R,MAM-2201(K i=5.4 nmol·L^(-1)),had higher binding affinity than WIN 55,212-2(K i=80 nmol·L^(-1)),and D9-THC(K i=8.3 nmol·L^(-1)).The E max values for MAM-2201 and WIN 55,212-2 in an assay of agonist inhibition of forskolin-stimulated c AMP were 85%(EC50=0.45 nmol·L^(-1)) and 95%,respectively,as compared with the D9-THC E max of 74%.In mice,MAM-2201(0.003-1.0 mg·kg^(-1),IP) produced dose-dependent cannabimimetic effects which were both more potent and more effective than those of D9-THC.MAM-2201 and D9-THC dose-dependently produced hypothermia:ED50=0.287 and 25.4 mg·kg^(-1),analgesia:ED50=0.125 and 29.4 mg·kg^(-1),and catalepsy:ED50=0.301 and18.9 mg·kg^(-1) in adult male CD1 mice.Importantly,MAM-2201 also elicited convulsant effects at a dose of 1.0 mg·kg^(-1) in 8/8 murine subjects.In rats,MAM-2201 produced dose-dependent D9-THC-like interoceptive effects in subjects trained to discriminate 3.0 mg·kg^(-1)(IP) D9-THC from saline.CONCLUSION MAM-2201 binds CB1 Rs with high affinity and agonist efficacy,and functions as a potent cannabinoid agonist in vivo across several complementary measures of cannabinoid activity in two rodent species.William E FANTEGROSSI Aaron JANOWSKY Amy J ESHLEMAN Lauren N RUSSELL Saki FUKUDA Jyoti GOGOI Cassandra PRIOLEAU Ambuja S BALE Srihari R TELLA Merle G PAULE Takato HIRANITA 2017中国药理学与毒理学杂志2017,31,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费